Evidence-Based Reviews

Choosing a treatment for disruptive, impulse-control, and conduct disorders

Author and Disclosure Information



In conjunction with emerging epidemio­logical data supporting a relatively high prevalence of disruptive, impulse-control, and conduct disorders, the small amount of data regarding effective treatments highlights the clinical need for additional research.

Bottom Line
Empirically supported treatment options for impulse-control disorders currently are limited, because only select disorders have been studied across multiple trials. New research is needed to confirm possible treatment options and identify effective psychotherapeutic and pharmacological treatment alternatives.

Related Resources
• Grant JE. Impulse control disorders: a clinician’s guide to un­derstanding and treating behavioral addictions. New York, NY: W. W. Norton & Company; 2008.
• Grant JE, Kim SW. Stop me because I can’t stop myself: tak­ing control of impulsive behavior. New York, NY: McGraw- Hill; 2003.
• American Academy of Child and Adolescent Psychiatry. Conduct disorder resource center. http://www.aacap.org/AACAP/FamiliesandYouth/ResourceCenters/ConductDisor....

Drug Brand Names
Atomoxetine • Strattera Methylphenidate • Ritalin
Carbamazepine • Tegretol Molindone • Moban
Citalopram • Celexa Naltrexone • ReVia
Clonazepam • Klonopin Olanzapine • Zyprexa
Clonidine • Catapres Oxcarbazepine • Trileptal
D-amphetamine • Dexedrine Quetiapine • Seroquel
Divalproex sodium • Depakote Risperidone • Risperdal
Escitalopram • Lexapro Sertraline • Zoloft
Fluoxetine • Prozac Sodium valproate • Depacon
Guanfacine • Intuniv Thioridazine • Mellaril
Haloperidol • Haldol Topiramate • Topamax
Levetiracetam • Keppra Valproic acid • Depakote
Lithium • Eskalith, Lithobid

Dr. Grant receives grant or research support from Brainsway, Forest Pharmaceuticals, and Roche Pharmaceuticals. Mr. Leppink reports no financial relationship with any company whose products are mentioned in this article or with competing products.


Next Article: